1.03
Calidi Biotherapeutics Inc (CLDI) Stock Split History
Calidi Biotherapeutics Inc has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on July 15, 2024 with the ratio of 1-for-10, meaning that for 10 shares of CLDI owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on July 31, 2026 on a 1-for-16 basis.
These splits have increased CLDI stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Calidi Biotherapeutics Inc's total market capitalization.
For more detailed information of Calidi Biotherapeutics Inc's stock splits, view the table below:
These splits have increased CLDI stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Calidi Biotherapeutics Inc's total market capitalization.
For more detailed information of Calidi Biotherapeutics Inc's stock splits, view the table below:
CLDI stock split list
| Date | Split Ratio |
|---|---|
| 2026-07-31 | 1 - for - 16 |
| 2025-08-05 | 1 - for - 12 |
| 2024-07-15 | 1 - for - 10 |
Will Calidi Biotherapeutics Inc Stock Split in 2026?
The answer will depend on the decisions of the company's managers and market volatility. Calidi Biotherapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CLDI stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Calidi Biotherapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):